Get started
Author

Oksana I. Ochirova

Observed names: O.I. Ochirova, Oksana Ochirova
OpenAlex ID: A5000837595
Clinical Outcomes in Patients With COVID-19 and Hematologic Disease
2023 · Olga A. Aleshina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia · 9
PDF
COVID-19 and hematologic diseases: Risk factors and long-term follow-up of CHRONOS19 Registry.
2021 · Kristina Zakurdaeva, Olga A. Gavrilina, et al. · Journal of Clinical Oncology · 4
P1692: Unmet Needs in Patients With “low Risk” Polycythemia Vera (pv): Symptom Burden and Quality of Life
2023 · Tatiana Nikitina, Ekena Andreevskaya, et al. · HemaSphere · 2
Efficacy of Isa-Pom-Dex Therapy in Double Refractory Multiple Myeloma (MM) Patients in Real Clinical Practice
2024 · Maxim Soloviev, Larisa Mendeleeva, et al. · Blood · 1
PDF
Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia
2021 · Olga A. Gavrilina, Kristina A. Zakurdaeva, et al. · Blood · 1
First Line BR in Chronic Lymphocytic Leukemia Patients: Interim Results of Russian Norma Trial
2014 · Elena Stadnik, Vladimir Strugov, et al. · Blood · 1
1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies
2021 · K. Zakurdaeva, O.A. Gavrilina, et al. · Annals of Oncology
PDF
ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry
2021 · Olga Gavrilina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia
Poster: ABCL-274: Outcomes in Patients with Lymphoproliferative Diseases and COVID-19: Results of a Subgroup Analysis of the CHRONOS19 Registry
2021 · Olga Gavrilina, Kristina Zakurdaeva, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 9
Citation count: 18
H-index: 2
I10-index:
Year
Topic
Type